Free Trial

Alyeska Investment Group L.P. Lowers Stake in Celsius Holdings Inc. $CELH

Celsius logo with Consumer Staples background

Key Points

  • Alyeska Investment Group L.P. sold 5,342,531 shares of Celsius Holdings Inc., reducing their stake by 77.7% to around 1,535,387 shares.
  • Celsius reported a significant earnings per share (EPS) of $0.47 for the last quarter, exceeding expectations by $0.24 and marking an 83.9% increase in revenue year-over-year.
  • Over 60.95% of Celsius stock is currently held by institutional investors, reflecting strong interest despite insider selling activity in recent months.
  • MarketBeat previews the top five stocks to own by October 1st.

Alyeska Investment Group L.P. trimmed its holdings in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 77.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,535,387 shares of the company's stock after selling 5,342,531 shares during the period. Alyeska Investment Group L.P. owned about 0.60% of Celsius worth $54,690,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Westside Investment Management Inc. bought a new position in Celsius during the first quarter worth about $32,000. Summit Securities Group LLC bought a new position in Celsius in the 1st quarter valued at about $34,000. MassMutual Private Wealth & Trust FSB raised its holdings in Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after acquiring an additional 750 shares during the period. UMB Bank n.a. raised its holdings in Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after acquiring an additional 844 shares during the period. Finally, Fifth Third Bancorp raised its holdings in Celsius by 62.9% in the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock valued at $61,000 after acquiring an additional 666 shares during the period. 60.95% of the stock is currently owned by institutional investors and hedge funds.

Celsius Stock Down 4.7%

Shares of NASDAQ:CELH traded down $2.73 during midday trading on Monday, hitting $55.64. 9,701,630 shares of the company's stock were exchanged, compared to its average volume of 8,081,112. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The stock has a 50 day moving average price of $51.32 and a 200-day moving average price of $41.24. The company has a market cap of $14.35 billion, a PE ratio of 150.38, a price-to-earnings-growth ratio of 1.32 and a beta of 1.33. Celsius Holdings Inc. has a 12 month low of $21.10 and a 12 month high of $63.50.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business had revenue of $739.30 million during the quarter, compared to the consensus estimate of $632.13 million. During the same period in the prior year, the firm posted $0.28 EPS. The firm's quarterly revenue was up 83.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Celsius Holdings Inc. will post 0.89 EPS for the current fiscal year.

Insider Transactions at Celsius

In other Celsius news, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $51.18, for a total value of $7,327,287.06. Following the completion of the transaction, the chief executive officer directly owned 895,410 shares of the company's stock, valued at $45,827,083.80. This trade represents a 13.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the transaction, the insider directly owned 17,717,770 shares of the company's stock, valued at approximately $841,594,075. The trade was a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,123,641 shares of company stock worth $52,998,580. 2.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CELH shares. Wells Fargo & Company increased their price target on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Wednesday, June 4th. JPMorgan Chase & Co. raised their target price on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a report on Thursday, July 31st. Morgan Stanley raised their target price on shares of Celsius from $56.00 to $61.00 and gave the stock an "equal weight" rating in a report on Tuesday, September 2nd. Stifel Nicolaus upped their target price on Celsius from $56.00 to $70.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. Finally, Cowen reiterated a "buy" rating on shares of Celsius in a report on Tuesday, September 2nd. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Celsius currently has a consensus rating of "Moderate Buy" and an average target price of $61.42.

View Our Latest Research Report on CELH

About Celsius

(Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Articles

Institutional Ownership by Quarter for Celsius (NASDAQ:CELH)

Should You Invest $1,000 in Celsius Right Now?

Before you consider Celsius, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.

While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.